Akero Therapeutics, Inc.

AKRONASDAQHealthcare

$54.65

+$0.00(+0.00%)

Market Cap$4.5B

P/E Ratio—

52W High$58.4

52W Low$21.34

Avg Volume2.6M

Open$54.52

Beta-0.40

Cash on Hand Financials Revenue

Akero Therapeutics, Inc. (AKRO) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

AKRO · cash on hand · updated Dec 31, 2024

Core cash position

as of Dec 31, 2024

Cash & Short-Term Investments (CCE + ST Investments)

$743.1M▲ +35.1% vs prior year

FY · as of Dec 31, 2024 · Reported in USD

Cash & Cash Equiv. (CCE)

$340.2M

cashAndCashEquivalents

Short-Term Investments

$402.8M

shortTermInvestments

YoY Change vs Prior Year

+35.1%

vs prior fiscal year

Latest Quarter

$737.8M

Q3 2025

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2024

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$743.1MCash on Hand

Total Debt$36.5MTotal Debt

Net Cash / Net Debt+$706.6MNet Cash Position

Cash vs Debt Ratio

Cash 95%Akero Therapeutics, Inc. cash as % of market cap: 16.52%% · MCap $4BDebt 5%

Akero Therapeutics, Inc. has a net cash position of $706.6M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$743.1M − $36.5M = +$706.6M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

AKRO annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

AKRO cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2024LatestFY$743.1M+35.1%

Dec 31, 2023FY$550.0M+56.5%

Dec 31, 2022FY$351.4M+86.7%

Dec 31, 2021FY$188.3M-29.9%

Dec 31, 2020FY$268.4M+96.8%

AKRO cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

AKRO vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Akero Therapeutics, Inc.YOU

AKRO

$743.1M$4B16.5%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Akero Therapeutics, Inc. (AKRO) cash on hand as of December 31, 2024 is $743.1M, comprising $340.2M in cash and cash equivalents (CCE) plus $402.8M in short-term investments — reported as Akero Therapeutics, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Akero Therapeutics, Inc. cash reserves or cash position.

Akero Therapeutics, Inc. annual cash on hand history shows increased +35.1% in 2024: increased +35.1% in 2024. Akero Therapeutics, Inc. cash reserves in 2024 reflect the company's capital allocation strategy.

Akero Therapeutics, Inc. carries total debt of $36.5M against cash of $743.1M, resulting in a net cash position of +$706.6M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

AKRO cash on hand · 5 questions

As of December 31, 2024, Akero Therapeutics, Inc. (AKRO) has $743,078,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $340,238,000 in cash and cash equivalents (CCE) plus $402,840,000 in short-term investments. Latest quarter (September 30, 2025): $737,826,000. Data sourced from the annual 10-K filing via FMP.

AKRO cash on handAKRO cash reservesAKRO cash 2024how much cash does AKRO have

▸ Source: FMP /balance-sheet-statement · US GAAP · Akero Therapeutics, Inc. · Akero Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2024